Because every product they develop increases the value of the company. What Nasrat is doing is going after many products. We know the tech works. It is no miracle drug. It is all known and understood and effective. So from one product to two to 15 products. As each one is developed, the value of the company goes up. And as each one passes trials, the value of the company goes up. And before long, it is a billion dollar company.
But I think they will end up getting bought out anyway. The more products in the queue, the more the company is worth. Simple really.
News 
Market Data 
Discover 
AI
